| Ticker Details |
|
Niagen Bioscience, Inc
|
| IPO Date: |
June 25, 2007 |
| Sector: |
Healthcare |
| Industry: |
Biotechnology |
| Market Cap: |
$387.86M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 2.59%
|
| Avg Daily Range (30 D): |
$0.12 | 2.01%
|
| Avg Daily Range (90 D): |
$0.13 | 2.04%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.82M |
| Avg Daily Volume (30 D): |
.71M |
| Avg Daily Volume (90 D): |
.73M |
| Trade Size |
| Avg Trade Size (Sh.): |
76 |
| Avg Trade Size (Sh.) (30 D): |
75 |
| Avg Trade Size (Sh.) (90 D): |
76 |
| Institutional Trades |
| Total Institutional Trades: |
195 |
| Avg Institutional Trade: |
$1.08M |
| Avg Institutional Trade (30 D): |
$.91M |
| Avg Institutional Trade (90 D): |
$.88M |
| Avg Institutional Trade Volume: |
.12M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.09M |
| Avg Closing Trade (30 D): |
$.77M |
| Avg Closing Trade (90 D): |
$.84M |
| Avg Closing Volume: |
121.15K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$.06
|
$.05
|
$.07
|
|
Diluted EPS
|
$.05
|
$.04
|
$.06
|
|
Revenue
|
$33.99M
|
$31.12M
|
$30.48M
|
|
Gross Profit
|
$21.93M
|
$20.23M
|
$19.33M
|
|
Net Income / Loss
|
$4.58M
|
$3.61M
|
$5.06M
|
|
Operating Income / Loss
|
$4.24M
|
$3.19M
|
$4.77M
|
|
Cost of Revenue
|
$12.06M
|
$10.89M
|
$11.15M
|
|
Net Cash Flow
|
$3.82M
|
$4.86M
|
$10.96M
|
|
PE Ratio
|
103.00
|
|
|
| Splits |
|
Dec 07, 2006
|
3.19:1
|
|
|
|
